Everett Rand Sutherland's most recent trade in Krystal Biotech Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | Everett Rand Sutherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Upstream Bio Inc | Everett Rand Sutherland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Everett Rand Sutherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Allakos Inc | Everett Rand Sutherland | Director | 01 Aug 2023 | 154,786 | 154,786 | - | - | Stock Option (Right to buy) | ||
| Krystal Biotech Inc | Everett Rand Sutherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 6,800 | 6,800 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Everett Rand Sutherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 6,800 | 6,800 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Everett Rand Sutherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 13,600 | 13,600 | - | - | Stock Option (Right to Buy) |